# Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder

> **NCT00252044** · NA · UNKNOWN · sponsor: **Bronx VA Medical Center**

## Conditions studied

- Schizotypal Personality Disorder
- Other Personality Disorders

## Interventions

- **DRUG:** Pergolide

## Key facts

- **NCT ID:** NCT00252044
- **Lead sponsor:** Bronx VA Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252044, "Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00252044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
